Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker ...
Solod, E. A., Armstrong, D. T., and Greep, R. O., Steroids (in the press). Savard, K., Marsh, J. M., and Rice, B. F., Rec. Prog. Hormone Res., 21, 285 (1965).